The rate of recurrent stroke was 4.6% in patients receiving the antihypertensive triple pill and 7.4% in those receiving ...

A three-drug combination pill lowered recurrent stroke risk in intracerebral hemorrhage survivors in the TRIDENT trial. The American Heart Association also announced a $15 million initiative to ...

Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...

Marcan Pharmaceuticals Inc. is recalling two lots of MAR-Amlodipine 5 mg tablets because some bottles may contain the wrong tablets, which they have identified as midodrine 2.5 mg tablets.

A large international trial showed that a once-daily triple pill combining low doses of telmisartan, amlodipine, and indapamide cut the risk of another stroke by nearly 40% in intracerebral hemorrhage ...

The present study was a multicentre, prospective, randomized, open and blinded end-point trial to assess the renoprotective effects of titrating the dose of an ARB, namely candesartan, and combined ...